A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

This study has been completed.

Study NCT00136461 Information provided by Dana-Farber Cancer Institute

First Received: August 25, 2005 Last Updated: January 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2000
Estimated Primary Completion Date:	No date given